The Cancer Letter

Inside information on cancer research and drug development

Vol.
35
No.
22
June 05, 2009Jun 05, 2009
Free
DOWNLOAD THE PDF

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

ASCO Begins Practice Certification Program

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account